1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Code

Showing 1,267 results.

$Thumbnail for Rondecabtagene Autoleucel, a Dual-Targeting CD19/CD20 CAR T-Cell Therapy, Exhibits a Manageable Safety Profile With Low Rates of Grade = 3 CRS and ICANS in Relapsed/Refractory Large B-Cell Lymphoma$

ABCL - 869

Rondecabtagene Autoleucel, a Dual-Targeting CD19/CD20 CAR T-Cell Therapy, Exhibits a Manageable Safety Profile With Low Rates of Grade = 3 CRS and ICANS in Relapsed/Refractory Large B-Cell Lymphoma

Francisco Hernandez

Poster Presenter: Francisco Hernandez

MM - 870

Isolated CNS Relapse Despite Systemic CR Following Extramedullary Disease in Primary Plasma Cell Leukemia

Sabaa Saad-Omer

Poster Presenter: Sabaa Saad-Omer

SOHO 2026 Annual Meeting

Posters by Code

Rondecabtagene Autoleucel, a Dual-Targeting CD19/CD20 CAR T-Cell Therapy, Exhibits a Manageable Safety Profile With Low Rates of Grade = 3 CRS and ICANS in Relapsed/Refractory Large B-Cell Lymphoma

Isolated CNS Relapse Despite Systemic CR Following Extramedullary Disease in Primary Plasma Cell Leukemia

Frailty as a Predictor of 30-Day Readmission in CAR-T Therapy Recipients

Characteristics and Clinical Outcomes of DDX41-Mutated Myeloid Neoplasms Treated with Lenalidomide: Single-Center Retrospective Study

Upfront Pemigatinib for Chronic-Phase Myeloid/Lymphoid Neoplasm with a Novel FGFR1 Rearrangement Presenting as Transient Bilateral Vision Loss: A Case Report.

Rising Fall- and Fracture-Associated Mortality Despite Declining Overall Multiple Myeloma Mortality in the United States, 2018-2024: National Trends, Fracture-Site Burden, and Disparities

Deep Remission, Delayed Immunity: Prospective Characterization of Normal B-Cell Reconstitution After Venetoclax Based Therapy in CLL and its Implications for Vaccination.

Real-World Safety Profile of Ciltacabtagene Autoleucel in Triple-Class Refractory Multiple Myeloma: A TriNetX Analysis.

Racial and Demographic Predictors of Time to Treatment Initiation and Survival Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) :A Retrospective Cohort Study